You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Erratum to: Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer’s Disease Patients: A Meta-Analysis and Critical Discussion

Susan Tomczak Matthiesen, Sophie Rosenkjær, Moa Pontén, Karin B. Jensen, Hanne Gottrup and Lene Vase

[Journal of Alzheimer’s Disease, 84(4) (2021), 1821-1832, 10.3233/JAD-210108]

https://content.iospress.com/articles/journal-of-alzheimers-disease/jad210108

In Figure 2 on page 1826 of the original version of this article, the labels “worsening” and “improvement” should be reversed. This issue is only related to Figure 2, and the in-text results are correct.

The updated and corrected Figure 2 has been placed in its entirety below.

Fig. 2

Forest plot of treatment responses in open-label and RCT pharmacological trials in AD patients. When studies included more than one outcome measure, they were reported as separate studies.

Forest plot of treatment responses in open-label and RCT pharmacological trials in AD patients. When studies included more than one outcome measure, they were reported as separate studies.